Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-005509
Filing Date
2020-08-04
Accepted
2020-08-04 17:01:55
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080420p.htm 10-Q 510551
2 EXHIBIT 31.1 exh_311.htm EX-31.1 9403
3 EXHIBIT 31.2 exh_312.htm EX-31.2 9346
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3266
5 EXHIBIT 32.2 exh_322.htm EX-32.2 3296
12 GRAPHIC logo.jpg GRAPHIC 112354
  Complete submission text file 0001171843-20-005509.txt   3387936

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE apto-20200630.xml EX-101.INS 588244
7 XBRL SCHEMA FILE apto-20200630.xsd EX-101.SCH 44740
8 XBRL CALCULATION FILE apto-20200630_cal.xml EX-101.CAL 29577
9 XBRL DEFINITION FILE apto-20200630_def.xml EX-101.DEF 267204
10 XBRL LABEL FILE apto-20200630_lab.xml EX-101.LAB 229875
11 XBRL PRESENTATION FILE apto-20200630_pre.xml EX-101.PRE 294110
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 201074081
SIC: 2836 Biological Products, (No Diagnostic Substances)